• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类前列腺中雄激素代谢酶的潜在活性。

Potential activities of androgen metabolizing enzymes in human prostate.

作者信息

Krieg M, Weisser H, Tunn S

机构信息

Institute of Clinical Chemistry, University Clinic Bergmannsheil, Bochum, Germany.

出版信息

J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):395-400. doi: 10.1016/0960-0760(95)00085-e.

DOI:10.1016/0960-0760(95)00085-e
PMID:7542902
Abstract

The entire androgen metabolism of the human prostate is an integral part of the DHT mediated cellular processes, which eventually give rise to the androgen responsiveness of the prostate. Therefore, the potential activities of various androgen metabolizing enzymes were studied. Moreover, the impact of aging on the androgen metabolism and the inhibition of 5 alpha-reductase by finasteride were studied. In epithelium (E) and stroma (S) of normal (NPR) and hyperplastic human prostate (BPH), for each enzyme being involved in the conversion either of testosterone via DHT, 3 alpha- and 3 beta-diol to the C19O3-triols or from testosterone to androstenedione and vice versa, the amount (Vmax) and Michaelis constant (Km) were determined by Lineweaver-Burk plots. Furthermore, Vmax/Km quotients were calculated, which served as an index for the potential enzyme activity. 17 enzymes showed a mean Vmax/Km > or = 0.10. The top four were the 5 alpha-reductases in E and S of NPR and BPH. Among those, the highest activity was found in E of NPR (1.6 +/- 0.2). Moreover, in E a significant age-dependent decrease of 5 alpha-reductase activity occurred, whereas in stroma rather constant activities were found over the whole age range. Similar age-dependent alterations were found for the cellular DHT levels. Finally, the finasteride inhibition of 5 alpha-reductase (IC50;nM) was stronger in E (35 +/- 17) than in S (126 +/- 15). In conclusion, 5 alpha-reductase is: (a) the outstanding androgen metabolizing enzyme in NPR and BPH; (b) dictating the DHT enrichment in the prostate; (c) under the impact of aging; and (d) preferentially inhibited by finasteride in E.

摘要

人类前列腺的整个雄激素代谢是双氢睾酮(DHT)介导的细胞过程的一个组成部分,最终导致前列腺对雄激素产生反应。因此,对各种雄激素代谢酶的潜在活性进行了研究。此外,还研究了衰老对雄激素代谢的影响以及非那雄胺对5α-还原酶的抑制作用。在正常(NPR)和增生性人类前列腺(BPH)的上皮(E)和基质(S)中,对于参与睾酮经DHT、3α-和3β-二醇转化为C19O3-三醇,或从睾酮转化为雄烯二酮及反之的每种酶,通过Lineweaver-Burk图测定其含量(Vmax)和米氏常数(Km)。此外,计算了Vmax/Km商数,其作为潜在酶活性的指标。17种酶的平均Vmax/Km≥0.10。排名前四位的是NPR和BPH的E和S中的5α-还原酶。其中,NPR的E中活性最高(1.6±0.2)。此外,在E中5α-还原酶活性出现显著的年龄依赖性下降,而在基质中,在整个年龄范围内活性相当恒定。细胞DHT水平也发现了类似的年龄依赖性变化。最后,非那雄胺对5α-还原酶的抑制作用(IC50;nM)在E中(35±17)比在S中(126±15)更强。总之,5α-还原酶是:(a)NPR和BPH中杰出的雄激素代谢酶;(b)决定前列腺中DHT的富集;(c)受衰老影响;(d)在E中优先被非那雄胺抑制。

相似文献

1
Potential activities of androgen metabolizing enzymes in human prostate.人类前列腺中雄激素代谢酶的潜在活性。
J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):395-400. doi: 10.1016/0960-0760(95)00085-e.
2
Effect of aging on kinetic parameters of 5 alpha-reductase in epithelium and stroma of normal and hyperplastic human prostate.衰老对正常及增生性人前列腺上皮和基质中5α-还原酶动力学参数的影响。
J Clin Endocrinol Metab. 1988 Nov;67(5):979-85. doi: 10.1210/jcem-67-5-979.
3
In vitro inhibition of androstenedione 5alpha-reduction by finasteride in epithelium and stroma of human benign prostatic hyperplasia.非那雄胺对人良性前列腺增生上皮和基质中雄烯二酮5α-还原的体外抑制作用
J Steroid Biochem Mol Biol. 1998 Oct;67(1):49-55. doi: 10.1016/s0960-0760(98)00071-5.
4
Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.衰老对人正常及增生前列腺上皮和基质中3α(β)-羟基类固醇氧化还原酶动力学参数的影响。
J Clin Endocrinol Metab. 1990 Sep;71(3):732-9. doi: 10.1210/jcem-71-3-732.
5
Kinetic parameters of 5 alpha-reductase activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates.正常、增生及癌性人类前列腺基质和上皮中5α-还原酶活性的动力学参数。
J Clin Endocrinol Metab. 1988 Oct;67(4):806-16. doi: 10.1210/jcem-67-4-806.
6
Kinetic analysis of androstenedione 5 alpha-reductase in epithelium and stroma of human prostate.人前列腺上皮和基质中雄烯二酮5α-还原酶的动力学分析
Steroids. 1997 Aug-Sep;62(8-9):589-94. doi: 10.1016/s0039-128x(97)00042-1.
7
Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.雄激素与雌激素:它们与人良性前列腺增生及正常前列腺的基质和上皮的相互作用。
J Steroid Biochem. 1983 Jul;19(1A):155-61.
8
5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor.正常和增生性人类前列腺培养上皮细胞和基质细胞中的5α-还原酶活性——5α-还原酶抑制剂非那雄胺(保列治)的作用
Cell Mol Biol (Noisy-le-grand). 1995 Dec;41(8):1007-15.
9
[Benign prostatic hyperplasia--the outcome of age-induced alteration of androgen-estrogen balance?].[良性前列腺增生——年龄诱导的雄激素 - 雌激素平衡改变的结果?]
Urologe A. 1997 Jan;36(1):3-9. doi: 10.1007/s001200050060.
10
Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.非那雄胺治疗的成年大鼠前列腺中的雄激素代谢:对雄性泌尿生殖道发育过程中睾酮和5α-二氢睾酮差异作用的一种可能解释。
Endocrinology. 1997 Mar;138(3):871-7. doi: 10.1210/endo.138.3.5009.

引用本文的文献

1
Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5α-Reductases.在大肠杆菌中表达、纯化及功能重建人源甾体 5α-还原酶。
Endocrinology. 2020 Aug 1;161(8). doi: 10.1210/endocr/bqaa117.
2
Estrogen and androgen signaling in the pathogenesis of BPH.雌激素和雄激素信号在 BPH 发病机制中的作用。
Nat Rev Urol. 2011 Jan;8(1):29-41. doi: 10.1038/nrurol.2010.207.
3
Antagonism of estrogen-mediated cell proliferation by raloxifene in prevention of ageing-related prostatic hyperplasia.雷洛昔芬通过拮抗雌激素介导的细胞增殖预防与衰老相关的前列腺增生。
Asian J Androl. 2010 Sep;12(5):735-43. doi: 10.1038/aja.2010.24. Epub 2010 May 17.
4
Proliferation and phenotypic changes of stromal cells in response to varying estrogen/androgen levels in castrated rats.去势大鼠中基质细胞响应不同雌激素/雄激素水平的增殖及表型变化
Asian J Androl. 2009 Jul;11(4):451-9. doi: 10.1038/aja.2009.28. Epub 2009 Jun 1.
5
Transient neonatal estrogen exposure to estrogen-deficient mice (aromatase knockout) reduces prostate weight and induces inflammation in late life.短暂性新生期雌激素暴露于雌激素缺乏的小鼠(芳香化酶基因敲除小鼠)会降低成年后的前列腺重量并引发炎症。
Am J Pathol. 2006 Jun;168(6):1869-78. doi: 10.2353/ajpath.2006.050623.
6
Finasteride: an update of its use in the management of symptomatic benign prostatic hyperplasia.非那雄胺:其在有症状良性前列腺增生管理中应用的最新进展
Drugs. 1999 Apr;57(4):557-81. doi: 10.2165/00003495-199957040-00008.
7
Clinical pharmacokinetics and pharmacodynamics of finasteride.
Clin Pharmacokinet. 1996 Jan;30(1):16-27. doi: 10.2165/00003088-199630010-00002.